Navigation Links
Olympus America Licenses Digital Pathology Patents to BioImagene, Inc.
Date:7/12/2010

CENTER VALLEY, Pa., July 12 /PRNewswire/ -- Olympus America Inc. has signed a nonexclusive worldwide licensing agreement with BioImagene, Inc. of Sunnyvale, California, allowing BioImagene to access an extensive portfolio of Olympus patents in the field of digital pathology and virtual microscopy. This is the most recent of several licenses that Olympus has granted for the technologies, which are considered critical for developing future digital imaging and data handling systems for pathology.  

Digital pathology technology has the potential to change the way doctors review and manage millions of biopsy slides and other pathology specimens now handled using glass slides and traditional optical microscopes.  The patents included in the licensing deal cover methods and equipment for creating, storing and delivering virtual microscopy slides. The technology enables pathologists to view and share high-resolution virtual microscopy images over the Internet.

"The digital pathology field is evolving rapidly," said F. Mark Gumz, President and CEO of Olympus Corporation of the Americas, the parent company of Olympus America Inc., "and allowing other companies in this field like BioImagene to license these important patents will help advance the field of pathology, and ultimately promote better access to healthcare for patients around the world."

"Digital pathology is at an important inflexion point, moving very rapidly towards broad-based adoption. We believe that our relationship with Olympus will be a catalyst for this trend," said Ajit Singh, Ph.D., President and CEO of BioImagene. "Olympus has been a pioneer in this field, and their patent portfolio will complement BioImagene's innovations in end-to-end digital pathology."

In the United States alone, $13.2 billion was spent in anatomic pathology testing during 2008, according to a 2010 Laboratory Economics report. The Olympus portfolio enables development of solutions that can streamline the review of pathology slides and improve the speed of reporting, while saving costs and enhancing patient care. Virtual microscope slide technology also has the potential to aid hospitals in moving to comprehensive patient Electronic Medical Record (EMR) systems – a transition that is already beginning in some parts of the world.

The companies are not making specific terms and conditions of the agreement public.

About Olympus Scientific Equipment Group

Olympus America Scientific Equipment Group provides innovative microscope imaging solutions for researchers, doctors, clinicians and educators. Olympus microscope systems offer unsurpassed optics, superior construction and system versatility to meet the ever-changing needs of microscopists, paving the way for future advances in life science.

About Olympus

Olympus is a precision technology leader, designing and delivering innovative solutions in its core business areas: Medical and Surgical Products, Life Science Imaging Systems, Industrial Testing Instruments and Cameras and Audio Products.

Olympus works collaboratively with its customers and affiliates worldwide to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:

  • Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
  • Advanced research, clinical and educational microscopes and research and educational digital imaging systems;
  • Industrial research, engineering, test, inspection and measuring instruments; and
  • Digital cameras and voice recorders.

Olympus serves the healthcare field with integrated product solutions and financial, educational and consulting services that help customers to efficiently, reliably and more easily achieve exceptional results. Olympus develops breakthrough technologies with revolutionary product design and functionality for the consumer and professional photography markets, and also is the leader in gastrointestinal endoscopy and clinical and educational microscopes.  For more information, visit www.olympusamerica.com.

About BioImagene

BioImagene (http://www.bioimagene.com) is the leading provider of innovative and scalable digital pathology solutions for diagnostics. The company's total digital pathology solution is comprised of the Virtuoso™ digital pathology application software, iScan™ family of automated digital slide scanners, and a rich menu of Companion Algorithms™. BioImagene's innovative product line includes a unique image viewing input device called the iSlide™, and a high-performance pathology workstation called Crescendo™. BioImagene is also the platinum sponsor of PathXchange™, a vendor neutral, not-for-profit website for the pathology community.


'/>"/>
SOURCE Olympus America Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Omnyx Licenses Olympus Digital Pathology Patents
2. Buenos Aires Welcomes CPhI South America 2010
3. Sysmex America Announces Amerinet Urinalysis Contract
4. Exagen Diagnostics Receives Lab Accreditation From College of American Pathologists
5. Profil Institute Teams Up With American Diabetes Association to Step Out Against Diabetes
6. Hot Times in the City: As Summer Temperatures Soar, Pulse of Passion Survey Reveals What Makes Americans Sizzle in Relationships
7. Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
8. Breast Cancer Patient First in Latin America to Receive Treatment Using Elekta VMAT Planned with Monaco Software
9. Sysmex America Announces Executive Leadership Changes
10. Dr. Harry J. Guttman, Esq. Invited Speaker at 2010 Central Regional Meeting of the American Chemical Society
11. InteKrin Therapeutics Presented Phase 2b Clinical Data at the 2010 American Diabetes Association Annual Meeting, Demonstrating Improved Glycemic Control in Patients with Type 2 Diabetes Without Causing the Edema Seen with Pioglitazone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):